Ledger.Open graph →
SEC Form D · filed August 24, 2023

Tango Therapeutics, Inc

Offering
$80.0M
Sold
$80.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
BOSTON, MA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (29)

Daniella Beckman · Boston, MAExecAlexis Borisy · Boston, MADirectorMalte A. Peters · Boston, MADirectorAdam Crystal · Boston, MAExecBarbara Weber · Boston, MAExec · DirectorMace A. Rothenberg · Boston, MADirectorLesley A. Calhoun · Boston, MADirectorAdam Crystal · Boston, MAExecAlexis Borisy · Boston, MADirectorMace A. Rothenberg · Boston, MADirectorLesley A. Calhoun · Boston, MADirectorBarbara Weber · Boston, MAExec · DirectorDaniella Beckman · Boston, MAExecMalte A. Peters · Boston, MADirectorDouglas Barry · Boston, MAExecAlan Huang · Boston, MAExecReid A. Huber · Boston, MADirectorAaron A. Davis · Boston, MADirectorRonald Poropatich · Pittsburgh, PADirectorMichael Kaufman · Pittsburgh, PAExecHouman Hemmati · Pittsburgh, PADirectorGretchen Kraemer · Pittsburgh, PADirectorCraig Nemiroff · Pittsburgh, PAExec · DirectorRobert E. Sanchez · SAN ANTONIO, TXExecEM Ascent Fund I GP, LLC · New York, NYDirectorDouglas Barry · Boston, MAExecAlan Huang · Boston, MAExecReid A. Huber · Boston, MADirectorAaron A. Davis · Boston, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗